MCCORMICK & CO INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MCCORMICK & CO INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $6.84B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $6.72B | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | $6.66B | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | $6.35B | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | $6.32B | Jan 25, 2024 |
| FY2020 | Nov 30, 2020 | $1.56B | Jan 28, 2021 |
| FY2020 | Aug 31, 2020 | $1.43B | Jan 28, 2021 |
| FY2020 | May 31, 2020 | $1.40B | Jan 28, 2021 |
| FY2020 | Feb 29, 2020 | $1.21B | Jan 28, 2021 |
| FY2020 | Nov 30, 2019 | $1.48B | Jan 28, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Nov 30, 2017 | $1.49B | Jan 25, 2018 |
| FY2017 | Aug 31, 2017 | $1.19B | Jan 25, 2018 |
| FY2017 | May 31, 2017 | $1.11B | Jan 25, 2018 |
| FY2017 | Feb 28, 2017 | $1.04B | Jan 25, 2018 |
| FY2017 | Nov 30, 2016 | $1.23B | Jan 25, 2018 |
| FY2017 | Aug 31, 2016 | $1.09B | Jan 25, 2018 |
| FY2017 | May 31, 2016 | $1.06B | Jan 25, 2018 |
| FY2017 | Feb 29, 2016 | $1.03B | Jan 25, 2018 |
| FY2016 | Nov 30, 2015 | $1.20B | Jan 25, 2017 |
| FY2016 | Aug 31, 2015 | $1.06B | Jan 25, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $2.59B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $2.59B | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | $2.50B | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | $2.27B | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | $2.49B | Jan 25, 2024 |
| FY2020 | Nov 30, 2020 | $660.70M | Jan 28, 2021 |
| FY2020 | Aug 31, 2020 | $590.30M | Jan 28, 2021 |
| FY2020 | May 31, 2020 | $579.50M | Jan 28, 2021 |
| FY2020 | Feb 29, 2020 | $469.90M | Jan 28, 2021 |
| FY2020 | Nov 30, 2019 | $630.00M | Jan 28, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $789.40M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $788.50M | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | $680.60M | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | $682.00M | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | $755.30M | Jan 25, 2024 |
| FY2020 | Nov 30, 2020 | $200.70M | Jan 28, 2021 |
| FY2020 | Aug 31, 2020 | $206.10M | Jan 28, 2021 |
| FY2020 | May 31, 2020 | $195.90M | Jan 28, 2021 |
| FY2020 | Feb 29, 2020 | $144.70M | Jan 28, 2021 |
| FY2020 | Nov 30, 2019 | $213.40M | Jan 28, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $1.07B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $1.06B | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | $963.00M | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | $863.60M | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | $1.02B | Jan 25, 2024 |
| FY2020 | Nov 30, 2020 | $274.90M | Jan 28, 2021 |
| FY2020 | Aug 31, 2020 | $273.00M | Jan 28, 2021 |
| FY2020 | May 31, 2020 | $257.40M | Jan 28, 2021 |
| FY2020 | Feb 29, 2020 | $194.20M | Jan 28, 2021 |
| FY2020 | Nov 30, 2019 | $299.20M | Jan 28, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $106.10M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $102.90M | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | $94.90M | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | $87.50M | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | $87.30M | Jan 25, 2024 |
| FY2022 | Nov 30, 2020 | $68.60M | Jan 26, 2023 |
| FY2021 | Nov 30, 2019 | $67.30M | Jan 27, 2022 |
| FY2020 | Nov 30, 2018 | $69.40M | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $66.10M | Jan 28, 2020 |
| FY2018 | Nov 30, 2016 | $61.00M | Jan 25, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $1.50B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $1.52B | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | $1.48B | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | $1.36B | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | $1.40B | Jan 25, 2024 |
| FY2022 | Nov 30, 2020 | $1.28B | Jan 26, 2023 |
| FY2021 | Nov 30, 2019 | $1.17B | Jan 27, 2022 |
| FY2020 | Nov 30, 2018 | $1.16B | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $1.03B | Jan 28, 2020 |
| FY2018 | Nov 30, 2016 | $1.18B | Jan 25, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $962.20M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $921.90M | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | $1.24B | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | $651.50M | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | $828.30M | Jan 25, 2024 |
| FY2022 | Nov 30, 2020 | $1.04B | Jan 26, 2023 |
| FY2021 | Nov 30, 2019 | $946.80M | Jan 27, 2022 |
| FY2020 | Nov 30, 2018 | $821.20M | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $815.30M | Jan 28, 2020 |
| FY2018 | Nov 30, 2016 | $658.10M | Jan 25, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Nov 30, 2022 | $262.00M | Jan 26, 2023 |
| FY2022 | Nov 30, 2021 | $278.00M | Jan 26, 2023 |
| FY2022 | Nov 30, 2020 | $225.30M | Jan 26, 2023 |
| FY2021 | Nov 30, 2019 | $173.70M | Jan 27, 2022 |
| FY2020 | Nov 30, 2018 | $169.10M | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $182.40M | Jan 28, 2020 |
| FY2018 | Nov 30, 2016 | $153.80M | Jan 25, 2019 |
| FY2017 | Nov 30, 2015 | $128.40M | Jan 25, 2018 |
| FY2016 | Nov 30, 2014 | $132.70M | Jan 25, 2017 |
| FY2015 | Nov 30, 2013 | $99.90M | Jan 28, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $13.20B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $13.07B | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | $12.86B | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | $13.12B | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | $12.91B | Jan 25, 2024 |
| FY2022 | Nov 30, 2020 | $12.09B | Jan 26, 2023 |
| FY2021 | Nov 30, 2019 | $10.36B | Jan 27, 2022 |
| FY2020 | Nov 30, 2018 | $10.26B | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $10.39B | Jan 28, 2020 |
| FY2018 | Nov 30, 2016 | $4.64B | Jan 25, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $7.43B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $7.75B | Jan 22, 2026 |
| FY2024 | Nov 30, 2023 | $7.78B | Jan 23, 2025 |
| FY2023 | Nov 30, 2022 | $8.43B | Jan 25, 2024 |
| FY2022 | Nov 30, 2021 | $8.48B | Jan 26, 2023 |
| FY2021 | Nov 30, 2020 | $8.15B | Jan 27, 2022 |
| FY2020 | Nov 30, 2019 | $6.91B | Jan 28, 2021 |
| FY2019 | Nov 30, 2018 | $7.07B | Jan 28, 2020 |
| FY2018 | Nov 30, 2017 | $7.81B | Jan 25, 2019 |
| FY2017 | Nov 30, 2016 | $3.00B | Jan 25, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $5.74B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $5.29B | Jan 22, 2026 |
| FY2024 | Nov 30, 2023 | $5.06B | Jan 23, 2025 |
| FY2023 | Nov 30, 2022 | $4.68B | Jan 25, 2024 |
| FY2022 | Nov 30, 2021 | $4.41B | Jan 26, 2023 |
| FY2021 | Nov 30, 2020 | $3.93B | Jan 27, 2022 |
| FY2020 | Nov 30, 2019 | $3.44B | Jan 28, 2021 |
| FY2019 | Nov 30, 2018 | $3.17B | Jan 28, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $5.30B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $5.23B | Jan 22, 2026 |
| FY2024 | Nov 30, 2023 | $5.26B | Jan 23, 2025 |
| FY2023 | Nov 30, 2022 | $5.21B | Jan 25, 2024 |
| FY2022 | Nov 30, 2021 | $5.34B | Jan 26, 2023 |
| FY2021 | Nov 30, 2020 | $4.99B | Jan 27, 2022 |
| FY2020 | Nov 30, 2019 | $4.51B | Jan 28, 2021 |
| FY2019 | Nov 30, 2018 | $4.53B | Jan 28, 2020 |
| FY2018 | Nov 30, 2017 | $4.49B | Jan 25, 2019 |
| FY2017 | Nov 30, 2016 | $1.77B | Jan 25, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $3.82B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $3.55B | Jan 22, 2026 |
| FY2024 | Nov 30, 2023 | $3.25B | Jan 23, 2025 |
| FY2023 | Nov 30, 2022 | $3.02B | Jan 25, 2024 |
| FY2022 | Nov 30, 2021 | $2.78B | Jan 26, 2023 |
| FY2021 | Nov 30, 2020 | $2.42B | Jan 27, 2022 |
| FY2020 | Nov 30, 2019 | $2.06B | Jan 28, 2021 |
| FY2019 | Nov 30, 2018 | $1.76B | Jan 28, 2020 |
| FY2018 | Nov 30, 2017 | $1.17B | Jan 25, 2019 |
| FY2017 | Nov 30, 2016 | $1.06B | Jan 25, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $95.90M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $186.10M | Jan 22, 2026 |
| FY2024 | Nov 30, 2023 | $166.60M | Jan 23, 2025 |
| FY2023 | Nov 30, 2022 | $334.00M | Jan 25, 2024 |
| FY2022 | Nov 30, 2021 | $351.70M | Jan 26, 2023 |
| FY2021 | Nov 30, 2020 | $423.60M | Jan 27, 2022 |
| FY2021 | Nov 30, 2019 | $155.40M | Jan 27, 2022 |
| FY2021 | Nov 30, 2018 | $96.60M | Jan 27, 2022 |
| FY2020 | Nov 30, 2017 | $186.80M | Jan 28, 2021 |
| FY2019 | Nov 30, 2016 | $118.40M | Jan 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $3.61B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $3.86B | Jan 22, 2026 |
| FY2024 | Nov 30, 2023 | $4.14B | Jan 23, 2025 |
| FY2023 | Nov 30, 2022 | $3.91B | Jan 25, 2024 |
| FY2022 | Nov 30, 2021 | $4.74B | Jan 26, 2023 |
| FY2021 | Nov 30, 2020 | $4.02B | Jan 27, 2022 |
| FY2020 | Nov 30, 2019 | $3.72B | Jan 28, 2021 |
| FY2019 | Nov 30, 2018 | $4.14B | Jan 28, 2020 |
| FY2018 | Nov 30, 2017 | $4.77B | Jan 25, 2019 |
| FY2017 | Nov 30, 2016 | $1.06B | Jan 25, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 2 | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | 2 | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | 2 | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | 2 | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | 2 | Jan 25, 2024 |
| FY2020 | Nov 30, 2020 | 0 | Jan 28, 2021 |
| FY2020 | Aug 31, 2020 | 0 | Jan 28, 2021 |
| FY2020 | May 31, 2020 | 0 | Jan 28, 2021 |
| FY2020 | Feb 29, 2020 | 0 | Jan 28, 2021 |
| FY2020 | Nov 30, 2019 | 0 | Jan 28, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 2 | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | 2 | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | 2 | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | 2 | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | 2 | Jan 25, 2024 |
| FY2020 | Nov 30, 2020 | 0 | Jan 28, 2021 |
| FY2020 | Aug 31, 2020 | 0 | Jan 28, 2021 |
| FY2020 | May 31, 2020 | 0 | Jan 28, 2021 |
| FY2020 | Feb 29, 2020 | 0 | Jan 28, 2021 |
| FY2020 | Nov 30, 2019 | 0 | Jan 28, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $483.00M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $451.00M | Jan 22, 2026 |
| FY2025 | Nov 30, 2023 | $418.50M | Jan 22, 2026 |
| FY2024 | Nov 30, 2022 | $396.70M | Jan 23, 2025 |
| FY2023 | Nov 30, 2021 | $363.30M | Jan 25, 2024 |
| FY2022 | Nov 30, 2020 | $330.10M | Jan 26, 2023 |
| FY2021 | Nov 30, 2019 | $302.20M | Jan 27, 2022 |
| FY2020 | Nov 30, 2018 | $273.40M | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $237.60M | Jan 28, 2020 |
| FY2018 | Nov 30, 2016 | $217.80M | Jan 25, 2019 |